NCT00951626
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
Clinical trial condition
Multiple Myeloma and Plasma Cell Neoplasm
Explore clinical trials studying Multiple Myeloma and Plasma Cell Neoplasm. Study availability and eligibility vary by location and protocol.
214 public trials
3 recruiting studies
Multiple Myeloma and Plasma Cell Neoplasm trial results
Completed
S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
NCT00898066
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +25 more
- Locations
-
Not specified
Completed
PAD. ICORG 05-01, V11
NCT00814541
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland
- Mater Misericordiae University Hospital Dublin, Ireland
- St. James's Hospital Dublin, Ireland
- University College Hospital Galway, Ireland
NCT00004258
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +83 more
- Locations
-
- Indiana University Cancer Center Indianapolis, Indiana, United States
NCT00589563
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
- Locations
-
- Banner Good Samaritan Medical Center Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT00003107
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
- Locations
-
- Indiana University Cancer Center Indianapolis, Indiana, United States
NCT00003572
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +46 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
NCT00003960
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
- Center for Cancer Treatment and Research Columbia, South Carolina, United States
Completed
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00003962
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +50 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
NCT00265837
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States